Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...
Northwestern Medicine scientists have uncovered new details explaining how poxviruses manipulate host cells to enhance their ...
In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...
圣地亚哥 - 市值7.96亿美元的生命科学试剂和服务供应商Maravai LifeSciences, Inc. (NASDAQ: MRVI)宣布收购Molecular Assemblies, Inc.的知识产权和资产。根据 InvestingPro 数据,该公司保持强劲的流动性,流动比率为10.74,尽管面临近期挑战,过去十二个月收入下降34%。此次收购将增强Maravai子公司TriLink ...
Touchlight, a pioneering leader in synthetic DNA technology, is pleased to announce the appointment of Will Downie as a key adviser to support its mission in advancing genetic medicines. Downie’s ...
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...
Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...
Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies.
Mexico’s first female president On October 1, Claudia Sheinbaum became Mexico’s first female and Jewish president, making history. In a nation where women were granted the right to vote only in 1953, ...
The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...
This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...